Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Take the Direct Route When Evaluating Training Effects in Lower Extremity Arterial Disease: Use Near Infrared Spectroscopy!

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Endovascular Treatment of Chronic and Acute on Chronic Mesenteric Ischaemia: Results From a National Cohort of 245 Cases

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Simulation Based Training and Assessment in Open Vascular Surgery: A Systematic Review

    Research output: Contribution to journalReviewResearchpeer-review

  1. Three-dimensional ultrasound improves identification of patients with abdominal aortic aneurysms reaching the threshold for repair

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Three-dimensional ultrasound is a reliable alternative in endovascular aortic repair surveillance

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Validation of an assessment tool for estimation of abdominal aortic aneurysm compression in diagnostic ultrasound

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: The risk of ipsilateral neurological recurrence (NR) was assessed in patients awaiting carotid endarterectomy (CEA) due to symptomatic carotid artery stenosis and whether current national guidelines of performing CEA within 14 days are adequate in present day practice.

METHODS: This was a retrospective multicentre observational cohort study. Patients scheduled for CEA due to symptomatic carotid artery stenosis in a five year period, 1 January 2014 to 31 December 2018, from four centres were included. Data from the Danish Vascular Registry (, operative managing systems, and electronic medical records were reviewed.

RESULTS: In total, 1 125 patients scheduled for CEA were included and 1 095 (97%) underwent the planned surgery. During a median delay from index event to CEA of 11 days (interquartile range 8-16 days), 40 patients (3.6%; 95% confidence interval [CI] 2.5%-5%) experienced a NR. One third were minor strokes (n = 12, 30%); half were transient ischaemic attacks (TIA) (n = 22, 55%); and amaurosis fugax accounted for 15% (n = 6). Twenty-six (2%) CEA procedures was cancelled, of which one was due to a disabling recurrent ischaemic event (aphasia). There were no deaths or major strokes in the waiting time for CEA. Best medical treatment (BMT) with platelet inhibitory or anticoagulation drugs and a statin was initiated in nearly all patients (98%) at first assessment. The overall 30 day risk of a post-operative major event (death or stroke) was (Kaplan-Meier [KM] estimate) 2.7% (95% CI 1.8-3.8), and not significantly correlated with the timing of surgery. Most (69%) occurred within the first three days. One, two, and three year mortality rate for CEA patients was (KM estimate) 4.8%, 7.8%, and 11.5% respectively.

CONCLUSION: In symptomatic carotid artery stenosis patients awaiting CEA, very few NRs occurred within 14 days. Institution of immediate BMT in specialised TIA/stroke units followed by early, but not necessarily urgent, CEA is a reasonable course of action in patients with high grade symptomatic carotid artery stenosis.

Original languageEnglish
JournalEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Issue number2
Pages (from-to)160-166
Number of pages7
Publication statusPublished - Aug 2021

Bibliographical note

Copyright © 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

    Research areas

  • Aged, Aged, 80 and over, Amaurosis Fugax/drug therapy, Anticoagulants/therapeutic use, Carotid Stenosis/complications, Denmark, Drug Therapy, Combination, Endarterectomy, Carotid/mortality, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemic Attack, Transient/etiology, Ischemic Stroke/etiology, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Complications/etiology, Recurrence, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Survival Rate, Time-to-Treatment

ID: 67939301